StockData
CEL SCI Corp logo

CEL SCI Corp (CVM) stock

CVMNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 2/30
$1.28+0.09 (+7.56%)

Close on Nov 13, 2026Market cap $22.51MP/E –Yield –

Cel Sci price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Cel Sci's price to book ratio was 2.1× on Nov 11, 2026, against 3.9× a year earlier. Over the last 5 years it ranged from 0.7× to 10.3×, with a median of 3.8×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20262.1×−0.5
2025Dec 31, 20252.6×+0.7
2024Dec 31, 20242.0×−7.8
2023Dec 29, 20239.8×+6.6
2022Dec 30, 20223.2×−2.3
2021Dec 31, 20215.4×−17.5
2020Dec 31, 202022.9×−39.9
2019Dec 31, 201962.8×+57.9
2017Apr 28, 20174.9×−15.4
2016Apr 29, 201620.3×+5.1
2015Oct 30, 201515.1×+10.7
2014Dec 31, 20144.4×+1.7
2013Dec 31, 20132.7×−7.8
2012Dec 31, 201210.5×+3.6
2011Dec 30, 20116.9×+0.8
2010Dec 31, 20106.0×−7.6
2009Dec 31, 200913.6×–

More Cel Sci figures

See a number that looks wrong?